Notes
British pounds
≥75% reduction in Psoriasis Area and Severity Index score
Reference
Mughal F, et al. Cost-Effectiveness of Apremilast in Moderate to Severe Psoriasis in the UK. 74th Annual Meeting of the American Academy of Dermatology : abstr. 3092, 4 Mar 2016. Available from: URL: https://www.aad.org/eposters/view/Abstract.aspx?id=3092
Rights and permissions
About this article
Cite this article
Apremilast cost effective for severe plaque psoriasis in UK. PharmacoEcon Outcomes News 750, 11 (2016). https://doi.org/10.1007/s40274-016-2934-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2934-3